Evidence map›Paper›PMID 40034795›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Investigating the relationship between breast cancer risk factors and an AI-generated mammographic texture feature in the Nurses' Health Study II.

Xueyao Wu, Shu Jiang, Aaron Ge, Constance Turman, Graham Colditz, Rulla M Tamimi, Peter Kraft

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Xueyao WuDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Shu JiangWashington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Aaron GeUniversity of Maryland School of Medicine, Baltimore, USA.
Constance TurmanProgram in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Graham ColditzWashington University School of Medicine in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-7307-0291
Rulla M TamimiPopulation Health Sciences Department, Weill Cornell Medical School, New York, New York, USA.
Peter KraftDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Funding

Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4M
Premonopausal Hormone Levels and Risk of Breast CancerR01CA067262 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HANKINSON, SUSAN E · 2002 to 2011
$11.9M
NCI NIH HHS R01 CA067262NCI NIH HHS U01 CA176726
6 · The paper itself

Abstract

Introduction: The mammogram risk score (MRS), an AI-driven texture feature derived from digital mammograms, strongly predicts breast cancer risk independently of breast density, though underlying mechanisms remain unclear. This study investigated relationships between established breast cancer risk factors, covering anthropometrics, reproductive factors, family history, and mammographic density metrics, and MRS. Methods: Using data from the Nurses' Health Study II (292 cases, 561 controls), we validated MRS's association with breast cancer using logistic regression and evaluated its relationships with risk factors through: linear regressions of MRS on observed risk factors and polygenic scores associated with risk factors, and Mendelian randomization (MR) analysis via two-stage least squares regression. We conducted two-sample MR of MRS using summary statistics from genome-wide association studies of risk factors. Results: MRS was significantly associated with breast cancer risk before adjustment for BI-RADS density (OR=1.92 per SD increase in MRS; 95%CI:1.57-2.33; AUC=0.69) and after (OR=1.85; 95%CI:1.49-2.30). Early life body size and adult body mass index (BMI) were inversely associated with MRS, while history of benign breast disease and BI-RADS density showed positive associations; after adjusting for BI-RADS density, associations between MRS and the other three risk factors attenuated. Higher polygenic score for dense area was associated with increased MRS (β=0.16 SD increase in MRS per SD increase in polygenic score; 95%CI: 0.06-0.25), as was percent density (β=0.14; 95%CI:0.05-0.23). Two-sample MR identified associations between genetically predicted dense area (β=0.83 SD increase in MRS per SD increase in dense area; 95%CI:0.39-1.27) and percent density (β=1.14; 95%CI:0.55-1.74) with MRS. After adjusting for BI-RADS density and BMI, higher waist-to-hip ratio was significantly associated with increased MRS in polygenic score and two-sample MR analyses. No significant associations were observed with other risk factors. Conclusion: We validated MRS's association with breast cancer risk in cases diagnosed 0.5-10.1 years (median 2.6) after mammogram acquisition. Our findings reveal robust associations between breast density measures and MRS and suggest a potential impact of central obesity on MRS. Future larger-scale studies are crucial to validate these results and explore their potential to enhance our understanding of breast cancer etiology and refine risk prediction models.

Identifiers

PMID40034795
PMCPMC11875271

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.